Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 26;21(5):1605. doi: 10.3390/ijms21051605

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Gemcitabine-eluting membrane (GEM) implantation suppresses the epithelial–mesenchymal transition (EMT) in xenograft tumors. (A,B) Transwell migration and invasion assays of SCK and PANC-1 cells. (C,D) Western blot analysis of E-cadherin, N-cadherin, snail, and vimentin expression at the bottom and top of SCK and PANC-1 tumor tissues after implantation with the GEM containing the indicated concentrations of gemcitabine. (E) Results of representative immunofluorescence analyses of E-cadherin, N-cadherin, snail, and vimentin in tissues from SCK tumors implanted with the GEM or control membrane.